Sickle cell disease in newborn screening: II. Reported bearers;Sikkelcelziekte in de hielprikscreening. II.

Nederlands Tijdschrift voor Geneeskunde

Volumn 153, Issue 18, 2009, Pages 858-861

  Vansenne, Fleur ^a   De Borgie, Corianne A J M ^a   Bouva, Marelle J ^b   Legdeur, Monica A ^a   Ven Zwieten, Rob ^c   Petrij, Fred ^d   Peters, Mariolein ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c Hemoglobinopathieonderzoek   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FEMALE; GENETIC SCREENING; GENETICS; HETEROZYGOTE DETECTION; HUMAN; MALE; NETHERLANDS; NEWBORN; NEWBORN SCREENING; PREVALENCE; RISK ASSESSMENT; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; FEMALE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; NETHERLANDS; PREVALENCE; RISK ASSESSMENT;

EID: 67449102387     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. 1 Giordano PC, Breuning MH. Van gen naar ziekte; van hemoglobinegenen naar thalassemie en sikkelcelanemie. Ned Tijdschr Geneeskd. 2000;144:1910-3.
2. Giordano PC, Bouva MJ, Harteveld CL. A confidential inquiry estimating the number of patients affected with sickle cell disease and thalassemia major confirms the need for a prevention strategy in the Netherlands. Hemoglobin. 2004;28:287-96.
3. Heijboer H, van den Tweel X, Peters M, Knuist M, Prins J, Heymans HS. Een jaar neonatale screening op sikkelcelziekte in het Emma Kinderziekenhuis/ Academisch Medisch Centrum te Amsterdam. Ned Tijdschr Geneeskd. 2ooi;i4S:i79S-9.
4. Almeida AM, Henthorn JS, Davies SC. Neonatal screening for haemoglobinopathies: the results of a 10-year programme in an English Health Region. Br J Haematol. 2001;112:32-5.
5. De Montalembert M, Bonnet D, Lena-Russo D, Briard ML. Ethical aspects of neonatal screening for sickle cell disease in Western European countries. Acta Paediatr. 2005;94:528-30.
6. Gulbis B, Tshilolo L, Cotton F, Lin C, Vertongen F. Newborn screening for haemoglobinopathies: the Brussels experience. J Med Screen. 1999;6:11-15.
7. Giordano PC, Harteveld CL. Preventie van erfelijke hemoglobinopathieën in Nederland. Ned Tijdschr Geneeskd. 2006;150:2137-41.
8. Kemper AR, Uren RL, Moseley KL, Clark SJ. Primary care physicians' attitudes regarding follow-up care for children with positive newborn screening results. Pediatrics. 2006;118:1836-41.
9. Modell B, Petrou M, Layton M, Varnavides L, Slater C, Ward RH, et al. Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years. BMJ. 1997;315:779-84.
10. Ahmed S, Atkin K, Hewison J, Green J. The influence of faith and religion and the role of religious and community leaders in prenatal decisions for sickle cell disorders and thalassaemia major. Prenat Diagn. 2006;26:801-9.
11. Asgharian A, Anie KA, Berger M. Women with sickle cell trait: reproductive decision-making. J Reprod Infant Psychol. 2003;21:23-34.
12. Giordano PC, Dihal AA, Harteveld CL. Estimating the attitude of immigrants toward primary prevention of the hemoglobinopathies. Prenat Diagn. 2005;25:885-93.